Thursday, January 5, 2017

BRIEF-Juniper Pharmaceuticals prototype formulation development for JNP-0301 is underway

* Prototype formulation development for jnp-0301 is

underway, with ind-enabling studies planned for 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)